EN DE
Watch Immsi S.p.A for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Immsi S.p.A (IMS) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Immsi S.p.A stock €0.58, price €0.55, upside +5.8%, quality 44 out of 100. Rating: fairly valued. Calculated from audited financials with 11 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Consumer Cyclical IT · ISIN IT0001413837

IS Immsi S.p.A logo Thin data Nov 7, 2026

Immsi S.p.A

IMS · MI
Fairly valued, weak quality

The stock costs about what our calculation considers fair.

Fair value €0.5800 · Fairly valued
Quality 44/100
Thin margins · 0.1% net margin (TTM)
Weak Growth (revenue 3y −9.2 %/yr in EUR)
High debt
Negative free cash flow
Trails peers (3/12)
Narrow moat 28/100 · thin data
Thin data
⟳ Cyclical
Watch Immsi S.p.A for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

€0.6900 €0.2774 Fair Value €0.5800 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 7, 2026.

How to read this chart

60‑month range €0.2774 – €0.6900 · fair‑value band €0.5200 – €0.6600 · the €0.5480 price screens below the €0.5800 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 7, 2026.

Follow Immsi S.p.A in your weekly email

Every Wednesday you see whether Immsi S.p.A is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Immsi S.p.A. operates in the real estate, industrial, and naval sectors in Italy, the rest of Europe, India, the United States, and internationally.

Show moreShow less

The company engages in the production and distribution of scooters, motorcycles, and light commercial vehicles; real estate development projects; Is Molas tourist hotel complex management; and production of defense ships, such as mine countermeasure vessels, fast patrol boats, hydrofoils, and fast ferries.

It also offers two-wheeler vehicles under the Aprilia, Derbi, Gilera, Moto Guzzi, Piaggio, Scarabeo, and Vespa brand names; and commercial vehicles under the Ape brand names. The company was founded in 2000 and is based in Mantua, Italy. Immsi S.p.A operates as a subsidiary of Omniainvest S.p.A.

Stock analysis

Immsi S.p.A (IMS) currently trades at €0.5480, while our model-based Fair Value estimate is €0.5800, so the stock looks roughly fairly valued today (gap 5.5%).

Show more

Valuation

Bull case: the Multiples group reads highest at a median of €2.23 per share, and 3 of the 9 models we run sit above the €0.5480 price.

Bear case: the Dividend Discount group reads lowest at €0.0850, and 6 of the 9 models stay below the price. Data coverage for this calculation is low.

Scenario range: €0.5200 (bear) to €0.6600 (bull), the price of €0.5480 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 44/100 (below-average quality), in the Consumer Cyclical sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

Immsi S.p.A reported revenue of €1.6B in FY2025 versus €1.7B in FY2021, a compound −1.8%/yr. Reported net income was €98.0K in FY2025, compounding −77.1%/yr from FY2021.

Key figures

Market cap €187M Micro · P/S ratio 0.11 · Dividend yield 2.2% · Net margin 0.1% · Return on equity 3.2% · Return on assets (EBIT) 5.7% (5-year average) · Operating margin 10.3% · Revenue (TTM) €1.6B.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 28 out of 100 (low confidence).

What moves the price

The share trades about 6% below its 52-week high and 21% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Consumer Cyclical peers we cover trades at 8% fair-value upside, at 6%, IMS screens richer than that median.

Fair Value models

Bear €0.5200 Fair Value €0.5800 Bull €0.6600
Price €0.5480 · Upside +5.8%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
Residual Income €0.2600 €0.2900 €0.3300 76
Gordon GGM €0.0700 €0.0800 €0.0900 69
DDM Multi-Stage €0.0700 €0.0900 €0.1000 67
All 11 models by family
Earnings-Based
EPV €0.0200 €0.2000 €0.3300 66
Dividend Discount
Gordon GGM €0.0700 €0.0800 €0.0900 69
DDM Multi-Stage €0.0700 €0.0900 €0.1000 67
Multiples
P/E Multiple n/a €0.0100 €0.0100 60
P/S Multiple n/a n/a €0.0100 53
EV/EBIT €1.57 €3.05 €4.53 63
EV/EBITDA €4.14 €6.47 €8.80 66
EV/Revenue €0.1300 €1.41 €2.69 47
Economic Profit
Residual Income €0.2600 €0.2900 €0.3300 76
ROIC Compounder €0.0200 €0.2000 €0.3300 66
Growth Earnings
Growth-Adj P/E n/a n/a €0.0100 64

The fair value above starts from this blend and is adjusted for a cyclical trough year.

Open the full fair value analysis →

Quality Score breakdown

Overall quality 44/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 30
How much profit the company makes from its sales and capital
Quality Growth 38
Are margins and returns getting better?
Cashflow 39
Do the profits arrive as real cash?
Financial strength 7
Debt, balance sheet and risk of trouble
Investment 85
Does it invest with discipline instead of growing at any price?
Low Volatility 75
How calm the share price moves, does not count
Price momentum 45
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 56
Distance to the 52-week high, does not count
New shares 82
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 26/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−8.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−9.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.0%
Start year 2020 (pandemic). Over 10 years: +1.6% a year
Revenue growth 22 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+11.3%
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis.
+5.5%
Earnings growth per share plus dividend.
Earnings per share, growth per year+3.3%
Dividend (yield on the price)2.2%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.5% → 7%

Watch IMS, get fair value alerts →

Compare Immsi S.p.A with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Auto Manufacturers · 106 stocks

Beats the industry median on 3/12 measures
Overall it trails its industry peers.
Valuation
Quality Score 44 · Below median
Fair Value upside +5.8% · Below median
Profitability
Return on equity (12 months) 3.2% · Below median
Return on assets 0.0% · Below median
Net margin (12 months) 0.1% · Below median
Operating margin (12 months) 10.3% · Top 25%
Growth and dividend
Revenue growth (quarter YoY) 6.7% · Below median
Dividend yield (12 months) 2.2% · Below median
Balance sheet
Debt / equity 3.64× · Highest 25%

Valuation Multiplesvs Auto Manufacturers median · lower = cheaper

P/B 0.95× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
P/S (12 months) 0.12× · Cheapest 25%
EV/EBITDA 3.5× · Cheapest 25%
PEG 27.34× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)41 · sector 45
FUTURE (revenue growth)34 · sector 37
PAST (return on equity)13 · sector 25
HEALTH (low debt)0 · sector 93
DIVIDEND (yield)45 · sector 53

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Auto Manufacturers stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Mercedes-Benz Group MBG €41.56 €106.12 +155% vs IMS
Ford Motor Company F $12.44 $19.90 +60% vs IMS
General Motors Company GM $86.16 $107.81 +25% vs IMS
Honda Motor Co HMC $35.78 $39.48 +10% vs IMS
Ferrari N.V RACE $416.13 $450.06 +8% vs IMS
Toyota Motor Corporation TM $216.19 $211.94 −2% vs IMS
Hyundai Motor Company 005380 279,500 KRW 257,654 KRW −8% vs IMS
BYD Company 002594 ¥85.23 ¥77.84 −9% vs IMS
Dr. Ing. h.c. F. Porsche AG P911 €47.06 €24.72 −47% vs IMS
Tesla, Inc TSLA $358.22 $40.00 −89% vs IMS

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Immsi S.p.A: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Immsi S.p.A Fair Value". https://www.fairvalue-calculator.com/stock/IMS

Frequently asked questions

Is Immsi S.p.A (IMS) overvalued or undervalued?
As of Nov 7, 2026, our model estimates a fair value of €0.5800 versus a price of €0.5480, about +6% upside (fairly valued).
What is the fair value of IMS?
Our model-based fair value for Immsi S.p.A is €0.5800 (as of Nov 7, 2026), built from audited fundamentals. The current price: €0.5480.
What is the quality score of IMS?
Immsi S.p.A has a Quality Score of 44/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Immsi S.p.A (IMS)?
Our model-based price target is the fair value of €0.5800 (as of Nov 7, 2026) from 11 valuation models. Cautious scenario €0.5200, optimistic scenario €0.6600. It is a calculation from audited fundamentals, not an analyst target.
What is the Immsi S.p.A stock forecast for 2026?
Our models put fair value at €0.5800, about +6% upside versus a price of €0.5480 (fairly valued). Cautious scenario €0.5200, optimistic scenario €0.6600. The calculation is refreshed regularly with new filings.
What is the revenue of Immsi S.p.A (IMS)?
Immsi S.p.A reported trailing-twelve-month revenue of about €1.6B (latest available figure, as of Nov 7, 2026).
Does Immsi S.p.A pay a dividend?
Immsi S.p.A currently shows a dividend yield of 2.24% relative to its recent price (as of Nov 7, 2026).
How much is the dividend of Immsi S.p.A (IMS)?
Immsi S.p.A has a dividend yield of 2.2%.
What is the intrinsic value of Immsi S.p.A (IMS)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Immsi S.p.A it is €0.5800 per share (as of Nov 7, 2026), against a price of €0.5480. It is the blended result of 11 valuation models in 5 families (Earnings-Based, Dividend Discount, Multiples, Economic Profit, Growth Earnings).
Is Immsi S.p.A stock overvalued or undervalued in 2026?
As of Nov 7, 2026, IMS trades below its calculated fair value: price €0.5480, fair value €0.5800, a gap of about +6% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of IMS?
No. The price is what the market pays today (€0.5480); the fair value is what the company's own numbers justify (€0.5800). For Immsi S.p.A the two are €0.0320 per share apart. That gap is exactly why we show both numbers side by side.
How much is Immsi S.p.A worth?
The market values Immsi S.p.A at about €187M (market capitalisation, as of Nov 7, 2026). Per share that is €0.5480; our models calculate a fair value of €0.5800 per share.
What do the bullish and bearish scenarios say about IMS?
Our models span a range for Immsi S.p.A: cautious scenario €0.5200, base €0.5800, optimistic €0.6600 per share (as of Nov 7, 2026, price €0.5480). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the PEG ratio of IMS?
The PEG ratio of Immsi S.p.A is 27.34 (P/E divided by earnings growth, as of Nov 7, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Immsi S.p.A (IMS)?
Balance-sheet figures for Immsi S.p.A (as of Nov 7, 2026): return on equity 3.2%, debt of 3.64 per unit of equity. They feed the Quality Score of 44/100, which measures business quality independently of the share price.
How far is IMS from its 52-week high?
Immsi S.p.A trades at €0.5480, about 6% below its 52-week high of €0.5840 and 21% above the low of €0.4535 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of €0.5800 is for.
Which stocks are comparable to Immsi S.p.A?
From the same area (Consumer Cyclical) we also value Tesla, Inc, Toyota Motor Corporation, BYD Company, Ferrari N.V, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Immsi S.p.A stock attractive at the current price?
The data as of Nov 7, 2026: price €0.5480, calculated fair value €0.5800 (+6%), Quality Score 44/100, from 11 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of IMS calculated?
We run Immsi S.p.A through 11 models from 5 families: Earnings-Based, Dividend Discount, Multiples, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of €0.5800 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Immsi S.p.A currently trades 6% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Immsi S.p.A (IMS)?
The closing price on Nov 6, 2026 was €0.5480. Our model-based fair value is €0.5800, about +6% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Immsi S.p.A right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Immsi S.p.A

How large is the market capitalisation of Immsi S.p.A (IMS)?
The market capitalisation of Immsi S.p.A is €187M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Immsi S.p.A (IMS)?
The price-to-sales ratio of Immsi S.p.A is 0.11 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of Immsi S.p.A (IMS)?
The dividend yield of Immsi S.p.A is 2.2%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Immsi S.p.A (IMS)?
The net margin of Immsi S.p.A is 0.1% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Immsi S.p.A (IMS)?
The return on equity (ROE) of Immsi S.p.A is 3.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Immsi S.p.A (IMS)?
On an EBIT basis the return on assets of Immsi S.p.A is 5.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Immsi S.p.A (IMS)?
The operating margin of Immsi S.p.A is 10.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Immsi S.p.A (IMS)?
Revenue at Immsi S.p.A is growing +6.7% versus a year earlier (3y avg −9.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Immsi S.p.A (IMS)?
Earnings per share at Immsi S.p.A are growing +10.9% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Immsi S.p.A (IMS) generate?
The free cash flow of Immsi S.p.A is −€13.9M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Immsi S.p.A (IMS) carry?
The net debt of Immsi S.p.A is €974M (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Immsi S.p.A in the live analysis

One click puts Immsi S.p.A on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.